Thus, ALDH18A1 promotes hepatocellular carcinoma cell proliferation, and inhibition of ALDH18A1 may be a novel therapeutic strategy for hepatocellular carcinoma.103. This evidence concerns the gene ALDH18A1 and hepatocellular carcinoma.